The national Covid19 recovery rate has touched 97.05 per cent, as 13 thousand 4 hundred 23 people were discharged in the last 24 hours. In the same period 8 thousand 6 hundred 55 new COVID-19 cases have also been reported. With this, total cases have reached 1 crore 7 lakh 66 thousand 245.
The Health Ministry said, till now 1 crore 4 lakh 48 thousand 406 people have been discharged. In the last 24 hours, 94 deaths were reported and the death toll has reached 1 lakh 54 thousand 4 hundred 86. Active cases now stand at 1 lakh 63 thousand 353.
The Union Health and Family Welfare Ministry said that Covid-19 vaccine developed by Bharat Biotech has the potential to also target mutated coronavirus strains.
In a written reply in the Rajya Sabha today, Minister of State for Health and Family Welfare Ministry, Ashwini Kumar Choubey said, the subject expert committee of Central Drugs Standard Control
Organization, CDSCO noted that the inactivated whole virion corona virus has the potential to target mutated corona virus strains. CDSCO has granted permission to manufacture of Covid-19 vaccines in the country to Serum Institute of India and Bharat Biotech International for restricted use in emergency situations.
In a reply to another question, the Minister informed that a total of 165 lakh doses of Covid-19 vaccine have been procured of which 110 lakh doses are of Covishield vaccine manufactured by the Serum Institute of India and 55 lakh doses are of Covaxin manufactured by Bharat Biotech.
He said, the total cost of procurement of above mentioned doses of vaccines is more than 350 crore rupees. He also informed that the common adverse events which have been reported from Covid-19 vaccines include headache, rash, chills, myalgia, fatigue, fever, dizziness and inflammation.